Lv5
990 积分 2023-05-19 加入
Nanobody-engineered bispecific IL-18 mimetics drive antitumor immunity by engaging CD8+ T cell and evading IL-18BP in preclinical models
8天前
已完结
Improved biodistribution and antitumor effects of a Nectin4 and Trop2 bispecific fatty acid-modified nanobody conjugate
8天前
已完结
Bi-specific monoclonal antibodies: selective binding and complement fixation to cells that express two different surface antigens
17天前
已完结
Distinctive functional characteristics of human „T”︁ lymphocytes defined by E rosetting or a monoclonal anti‐T cell antibody
17天前
已完结
Parameters of long-term response with CD28-based CD19 chimaeric antigen receptor-modified T cells in children and young adults with B-acute lymphoblastic leukaemia
21天前
已完结
CAR T cell persistence in cancer
22天前
已完结
Immunogenicity of engineered antibodies
23天前
已完结
Chimeric STAR receptors using TCR machinery mediate robust responses against solid tumors
2个月前
已完结
T cell receptor gene therapy: strategies for optimizing transgenic TCR pairing
2个月前
已完结
皖公网安备34019202002308
